1 to 3 of 3 literature results

• Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients.

  Dendritic cell (DC) targeting in vivo has recently been shown to confer strong and protective cytotoxic T lymphocyte (CTL)-based immunity in tumor mur…

  Authors: Raffaella Fontana, Marco Bregni, Arcadi Cipponi, Laura Raccosta, Cristina Rainelli, Daniela Maggioni, Francesca Lunghi, Fabio Ciceri, Sylvain Mukenge, Claudio Doglioni,…

  Source: Blood. 2009 Feb 19

  View Full Text

• Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.

  The exploitation of the physiologic processing and presenting machinery of DCs by in vivo loading of tumor-associated antigens may improve the immunog…

  Authors: Vincenzo Russo, Arcadi Cipponi, Laura Raccosta, Cristina Rainelli, Raffaella Fontana, Daniela Maggioni, Francesca Lunghi, Sylvain Mukenge, Fabio Ciceri, Marco Bregni,…

  Source: The Journal of clinical investigation. 2007 Oct

  View Free Full Text

• Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion.

  Polymyxin B is a lipopolysaccharide binding antibiotic used to inactivate potential lipopolysaccharide contaminations when evaluating the activity of …

  Authors: Barbara Valentinis, Alessandro Bianchi, Dan Zhou, Arcadi Cipponi, Federica Catalanotti, Vincenzo Russo, Catia Traversari

  Source: The Journal of biological chemistry. 2005 Apr 8

  View Full Text